Towa Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	49,576	45,471	29,650	24,257	32,830	22,915
Cash & Short-Term Investments	49,576	45,471	29,650	24,257	32,830	22,915
Cash Growth	20.13%	53.36%	22.23%	-26.11%	43.27%	22.45%
Receivables	67,038	71,631	71,657	54,392	50,748	45,784
Inventory	118,505	108,287	101,072	92,927	72,701	60,951
Other Current Assets	20,865	21,917	15,339	11,414	10,585	7,640
Total Current Assets	255,984	247,306	217,718	182,990	166,864	137,290
Property, Plant & Equipment	170,809	168,423	153,642	127,004	100,857	85,898
Long-Term Investments	10,280	3,213	3,006	3,104	3,035	3,277
Goodwill	26,234	28,115	32,568	34,613	44,647	7,050
Other Intangible Assets	17,222	17,727	18,018	18,332	9,455	7,913
Long-Term Deferred Tax Assets	-	6,037	5,699	5,303	5,075	4,239
Other Long-Term Assets	1	2	2	1	2	1
Total Assets	480,530	470,823	430,653	371,347	329,935	245,668
Accounts Payable	30,260	30,041	26,372	36,070	29,076	23,168
Accrued Expenses	-	112	96	117	108	100
Short-Term Debt	5,784	10,057	6,927	15,224	52,762	3,486
Current Portion of Long-Term Debt	23,814	18,023	10,120	7,527	12,172	7,181
Current Portion of Leases	1,604	1,383	-	-	-	-
Current Income Taxes Payable	4,060	20,334	23,911	14,012	15,536	12,069
Other Current Liabilities	25,760	7,989	12,692	5,579	5,419	5,512
Total Current Liabilities	91,282	87,939	80,118	78,529	115,073	51,516
Long-Term Debt	192,069	195,077	189,124	150,314	79,194	74,098
Long-Term Leases	12,992	11,801	-	-	-	-
Pension & Post-Retirement Benefits	149	141	220	322	547	540
Other Long-Term Liabilities	4,176	4,241	5,299	5,288	2,952	2,916
Total Liabilities	300,668	299,199	274,761	234,453	197,766	129,070
Common Stock	4,717	4,717	4,717	4,717	4,717	4,717
Additional Paid-In Capital	7,842	7,841	7,838	7,837	7,837	7,834
Retained Earnings	156,747	150,502	134,452	121,232	122,131	108,629
Treasury Stock	-5,584	-5,586	-5,606	-5,608	-5,608	-5,626
Comprehensive Income & Other	16,140	14,150	14,491	8,716	3,092	1,044
Shareholders' Equity	179,862	171,624	155,892	136,894	132,169	116,598
Total Liabilities & Equity	480,530	470,823	430,653	371,347	329,935	245,668
Total Debt	236,263	236,341	206,171	173,065	144,128	84,765
Net Cash (Debt)	-186,687	-190,870	-176,521	-148,808	-111,298	-61,850
Net Cash Per Share	-3792.36	-3877.50	-3586.33	-3023.21	-2211.60	-1206.18
Filing Date Shares Outstanding	49.23	49.23	49.22	49.22	49.22	49.21
Total Common Shares Outstanding	49.23	49.23	49.22	49.22	49.22	49.21
Working Capital	164,702	159,367	137,600	104,461	51,791	85,774
Book Value Per Share	3653.66	3486.37	3167.24	2781.16	2685.17	2369.18
Tangible Book Value	136,406	125,782	105,306	83,949	78,067	101,635
Tangible Book Value Per Share	2770.91	2555.14	2139.49	1705.52	1586.02	2065.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.